Quantum SI
Guilford
About Quantum SI
Quantum-Si is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $525.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:QSI
- Website: quantum-si.com
- Phone: +1 866-688-7374
Industries & Categories
Biotechnology, Health Diagnostics, Life Science, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/quantum-si-85898 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.